Potassium Chloroplatinate Description
Potassium Chloroplatinate is a potassium compound and can be prepared by reacting potassium hexachloroplatinate (IV) with cuprous chloride.
Potassium Chloroplatinate Specifications
CAS Number
|
10025-99-7
|
Molecular Formula
|
K2PtCl4
|
Molecular Weight
|
415.09
|
Appearance
|
Reddish brown
|
Theoretical Metal Content:
|
47%
|
Melting Point
|
250 °C
|
Sensitivity
|
Hygroscopic
|
Solubility
|
Soluble in water 10 g/L (20 ºC)
|
Potassium Chloroplatinate Applications
Potassium Chloroplatinate Powder can be used for research and hydrosilylation catalysts.
Potassium Chloroplatinate Safety Information
Symbol
|
GHS05; GHS06; GHS08
|
Signal Word
|
Danger
|
Hazard Statements
|
H301-H315-H317-H318-H334
|
Precautionary Statements
|
P261-P280-P301 + P310-P305 + P351 + P338-P342 + P311
|
Personal Protective Equipment
|
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
|
RIDADR
|
UN 3288 6.1 / PGIII
|
WGK Germany
|
1
|
Potassium Chloroplatinate FAQs
Q1. How is Potassium Tetrachloroplatinate(II) Powder produced?
It is typically produced by reacting platinum with hydrochloric acid and potassium chloride under controlled conditions.
Q2. How should Potassium Tetrachloroplatinate(II) Powder be stored?
Store in a cool, dry place away from incompatible materials such as strong oxidizing agents. Ensure the container is tightly sealed to prevent moisture absorption and contamination.
Q3. Can Potassium Tetrachloroplatinate(II) Powder be used in medical applications?
While it is primarily used in industrial and research applications, it can be a precursor for platinum-based drugs used in chemotherapy. However, its direct use in medical applications should be under strict regulatory control.